AstraZeneca to Invest in New Biological Manufacturing Facility in Sweden; To Create 150-250 Jobs By 2019

By: via Benzinga
AstraZeneca (NYSE: AZN) today announced that it plans to invest approximately $285 million in a new high-tech facility for manufacturing ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.